The FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer Narmafotinib, an investigational drug,…
Latest News
-
-
Investing
Saskatchewan Research Council Hits Milestone with Rare Earths Facility Commercial Production
by adminThe groundbreaking achievement of commercial production at the Rare Earths Processing Facility by the Saskatchewan…
-
Silver Crown Royalties Inc: A New Player on the OTC Markets Group’s OTCQX Silver Crown…
-
The House Democrats’ Plan Raises Buzz with Multimedia Project for 2025 Hearing The announcement made…
-
In the latest political development, former President Donald Trump has once again stirred controversy by…
-
The recent vice presidential debate between Kamala Harris and Mike Pence has sparked a plethora…
-
In today’s ever-evolving market landscape, astute investors are constantly on the lookout for strategies that…
-
Spy operatives rely on a wide array of skills and strategies to gain access into…
-
The recent decision by the Federal Reserve to cut interest rates has sent shockwaves through…
-
Investing
Bold Ventures: Third Tranche Closed, Private Placement Extended, and Insiders Subscribing
by adminBold Ventures Announces Closing of Third Tranche Extension of Non-Brokered Private Placement and Insider Subscriptions…